Francesc Marco
About
In The Last Decade
Francesc Marco
274 papers receiving 9.7k citations
Hit Papers
Peers
Comparison fields: 5 of 141
- Epidemiology 5.4k
- Infectious Diseases 3.7k
- Molecular Medicine 2.4k
- Clinical Biochemistry 2.0k
- Pharmacology 1.4k
Countries citing papers authored by Francesc Marco
This map shows the geographic impact of Francesc Marco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Francesc Marco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Francesc Marco more than expected).
Fields of papers citing papers by Francesc Marco
This network shows the impact of papers produced by Francesc Marco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Francesc Marco. The network helps show where Francesc Marco may publish in the future.
Co-authorship network of co-authors of Francesc Marco
This figure shows the co-authorship network connecting the top 25 collaborators of Francesc Marco. A scholar is included among the top collaborators of Francesc Marco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Francesc Marco. Francesc Marco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 5 | |
| 4 | 1 | |
| 5 | 2 | |
| 6 | 14 | |
| 7 | 22 | |
| 8 | Tiempo de positividad, tipo de medio de cultivo y prueba de oxidasa realizada en viales de hemocultivo positivos para predecir Pseudomonas aeruginosa en pacientes con bacteriemia por bacilos gramnegativos | 1 |
| 9 | Detección de resistencia a agentes antibacterianos mediante MALDI-TOF espectrometría de masas | 2 |
| 10 | 49 | |
| 11 | Epidemiología y forma de presentación clínica de las infecciones originadas por Staphylococcus aureus resistente a meticilina productor de leucocidina de Panton-Valentine | 5 |
| 12 | Trend in Glycopeptide and Daptomycin Susceptibility in Coagulase-Negative Staphylococci (CoNS) Isolated from Infective Endocarditis (IE) Over Time (1992-2007). | 2 |
| 13 | Bacteriemia por Staphylococcus aureus resistente a meticilina. Factores asociados al aislamiento de cepas con concentración mínima inhibitoria de vancomicina > 2 mg/L | 2 |
| 14 | 13 | |
| 15 | Infección por Staphylococcus aureus resistente a la meticilina | 2 |
| 16 | Avances en el tratamiento antimicrobiano de la endocarditis infecciosa en el año 2000 | 1 |
| 17 | 380 | |
| 18 | 130 | |
| 19 | 131 | |
| 20 | 2 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.